MAP Pharmaceuticals Announces Termination of Pediatric Asthma Collaboration

Full story: Pharmaceutical Processing

MAP Pharmaceuticals, Inc. has announced that it has received a notice of termination of the license agreement with AstraZeneca related to the company's Unit Dose Budesonide product candidate.

Leave a Comment

Comments

Type in your comments to post to the forum

Name
(appears on your post)

Comments

Type the numbers you see in the image on the right:

Please note by clicking on "Post Comment" you acknowledge that you have read the Terms of Service and the comment you are posting is in compliance with such terms. Be polite. Inappropriate posts may be removed by the moderator. Send us your feedback.

Other Recent Asthma Discussions

Topic	Updated	Last By	Comments
Asthma Management	Fri	exhalednitri...	2
New Warnings for 3 Asthma Drugs (Aug '06)	Nov 10	Don	23
Psychiatric warning added to labels of leukotri...	Nov 9	been there l...	4
Monavie..a natural alternative to medication fo... (May '06)	Nov 3	claudia monavie	46
Asthma Sufferers At A Higher Risk Of Catching H1N1	Nov 3	Kate Johnson...	1
Trying to inhale: Asthma sufferers say CFC-free...	Oct 28	Lynn	2
FDA Looks Ahead to Withdrawal of Nonprescriptio...	Oct 28	Lynn	1